logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
L

Lixian Wu

fujian medical university

19H指数
71论文数
922被引数
收录论文 18
发表时间
logo
The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBCSP1-超级增强子-SPHK1轴介导了Niraparib对TNBC的耐药性
errPharmaceuticals 2025, Vol. 18, Page 1622
IF4.8
err2025-10-27
err0
errOAAI
errYu-Xia Yuan; Rui-Jia Chen; Gui-Hui Tu; Chao-Qi Li; Long-Long Xu; Yi-Ling Lu; Li-Xian Wu
err分享
err收藏
Modulating NPC1L1 to Potentiate PARP Inhibitor-Induced Ferroptosis and Immune Response in Triple-Negative Breast Cancer通过调节NPC1L1来增强PARP抑制剂诱导的铁死亡和免疫反应在 triple-negative breast cancer 中的作用
errPHARMACEUTICS
IF5.5
err2025-04-24
err0
errOAAI
errLi, Ge; Yuan, Yuxia; Wu, Xinhua; Wu, Lixian
err分享
err收藏
A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer
errBIOCHEMICAL PHARMACOLOGY
IF5.6
err2022-12-01
err38
PREAI
errLi, Ge; Lin, Shan-shan; Yu, Ze-lei; Wu, Xin-hua; Liu, Jing-wen; Tu, Gui-hui; Liu, Quan-yu; Tang, Yuan-ling; Jiang, Qing-na; Xu, Jian-hua; Huang, Qing-ling; Wu, Li-xian
err分享
err收藏
Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancers新型PARP和EGFR双靶点抑制剂的合成及其在三阴性乳腺癌中的抗肿瘤活性
errBIOORGANIC & MEDICINAL CHEMISTRY
IF3
err2022-05-01
err11
PREAI
errLin, Shanshan; Zhang, Xiao; Yu, Zelei; Huang, Xiuwang; Xu, Jianhua; Liu, Yang; Wu, Lixian
err分享
err收藏
Positive Feedback Regulation of Poly(ADP-ribose) Polymerase 1 and the DNA-PK Catalytic Subunit Affects the Sensitivity of Nasopharyngeal Carcinoma to Etoposide
errACS OMEGA
IF4.3
err2022-01-07
err3
errOAAI
errZhang, Lingyu; Zhuang, Yingting; Tu, Guihui; Li, Ding; Fan, Yingjuan; Ye, Shengnan; Xu, Jianhua; Zheng, Ming; Wu, Ying; Wu, Lixian
err分享
err收藏
Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer发现BP3作为HSP90的有效蛋白水解靶向嵌合体 (PROTAC) 降解剂用于治疗乳腺癌
errEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
IF5.9
err2022-01-01
err26
PREAI
errLiu, Quanyu; Tu, Guihui; Hu, Yan; Jiang, Qingna; Liu, Jingwen; Lin, Shanshan; Yu, Zelei; Li, Ge; Wu, Xinhua; Tang, Yuanling; Huang, Xiuwang; Xu, Jianhua; Liu, Yang; Wu, Lixian
err分享
err收藏
Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer
errINTERNATIONAL JOURNAL OF NANOMEDICINE
IF6.5
err2020-06-01
err56
errOAAI
errZhang, Lingyu; Chen, Wenshu; Tu, Guihui; Chen, Xingyong; Lu, Youguang; Wu, Lixian; Zheng, Dali
err分享
err收藏
The role of the novel LincRNA uc002jit.1 in NF-kB-mediated DNA damage repair in acute myeloid leukemia cells
errEXPERIMENTAL CELL RESEARCH
IF3.5
err2020-06-01
err3
PREAI
errLi, Ding; Yu, Zelei; Wang, Tingting; Li, Yi; Chen, Xianling; Wu, Lixian
err分享
err收藏
Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activities新型PARP和HSP90双靶点抑制剂的合成及其抗肿瘤活性研究
errBIOORGANIC & MEDICINAL CHEMISTRY
IF3
err2020-05-01
err27
PREAI
errLin, Shanshan; Zhang, LingYu; Zhang, Xiao; Yu, Zelei; Huang, Xiuwang; Xu, Jianhua; Liu, Yang; Chen, Limin; Wu, Lixian
err分享
err收藏
RETRACTION: Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin (Retraction of Vol 22, Pg 1402, 2008)
errLEUKEMIA
IF13.4
err2020-04-08
err0
errOAAI
errWu, L. X.; Xu, J. H.; Zhang, K. Z.; Lin, Q.; Huang, X. W.; Wen, C. X.; Chen, Y. Z.
err分享
err收藏
Studies on molecular mechanism between ACE and inhibitory peptides in different bioactivities by 3D-QSAR and MD simulations
errJOURNAL OF MOLECULAR LIQUIDS
IF5.2
err2020-04-01
err33
PREAI
errYan, Wenli; Lin, Guimei; Zhang, Rong; Liang, Zhen; Wu, Lixian; Wu, Wenjuan
err分享
err收藏
NF-κB and Poly (ADP-ribose) Polymerase 1 Form a Positive Feedback Loop that Regulates DNA Repair in Acute Myeloid Leukemia Cells
errMOLECULAR CANCER RESEARCH
IF4.7
err2019-03-01
err25
errOAAI
errLi, Ding; Luo, Yufei; Chen, Xianling; Zhang, LingYu; Wang, Tingting; Zhuang, Yingting; Fan, Yingjuan; Xu, Jianhua; Chen, Yuanzhong; Wu, Lixian
err分享
err收藏
Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11-7082
errJOURNAL OF CANCER
IF3.2
err2019-01-01
err49
errOAAI
errZhang, Lingyu; Xie, Jing; Gan, Ruihuan; Wu, Zhangwei; Luo, Huatian; Chen, Xingyong; Lu, Youguang; Wu, Lixian; Zheng, Dali
err分享
err收藏
Effects of FM0807, a novel curcumin derivative, on lipopolysaccharide-induced inflammatory factor release via the ROS/JNK/p53 pathway in RAW264.7 cells
errBIOSCIENCE REPORTS
IF4.7
err2018-10-17
err8
errOAAI
errWu, Yilong; Liu, Zhiwei; Wu, Weifang; Lin, Su; Zhang, Nanwen; Wang, Honglin; Tan, Shuangyu; Lin, Peimin; Chen, Xiaole; Wu, Lixian; Xu, Jianhua
err分享
err收藏
A novel synthetic novobiocin analog, FM-Nov17, induces DNA damage in CML cells through generation of reactive oxygen species
errPHARMACOLOGICAL REPORTS
IF3.8
err2016-04-01
err2
PREAI
errZhang, Nanwen; Huang, Lisen; Tian, Jue; Chen, Xianling; Ke, Fang; Zheng, Ming; Xu, Jianhua; Wu, Lixian
err分享
err收藏
RETRACTED: Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin (Retracted article. See vol. 34, pg. 1722, 2020)
errLEUKEMIA
IF13.4
err2008-04-17
err44
PREAI
errWu, L. X.; Xu, J. H.; Zhang, K. Z.; Lin, Q.; Huang, X. W.; Wen, C. X.; Chen, Y. Z.
err分享
err收藏
Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells
errACTA PHARMACOLOGICA SINICA
IF8.4
err2007-01-01
err17
errOAAI
errZhang, Kun-zhong; Xu, Jian-hua; Huang, Xiu-wang; Wu, Li-xian; Su, Yu; Chen, Yuan-zhong
err分享
err收藏
Down-regulation of p210bcr/abl by curcumin involves disrupting molecular chaperone functions of Hsp90姜黄素下调p210bcr/abl涉及破坏Hsp90的分子伴侣功能
errACTA PHARMACOLOGICA SINICA
IF8.4
err2006-06-01
err41
errOAAI
errWu, Li-Xian; Xu, Jian-Hua; Huang, Xiu-Wang; Zhang, Kun-Zhong; Wen, Cai-Xia; Chen, Yuan-Zhong
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
李丁 封面图
李丁 (Li Ding)
H 指数: 135 · 论文数: 1.1K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
吴鑫华 封面图
吴鑫华 (Xinhua Wu)
H 指数: 61 · 论文数: 282
G
Ge Li
H 指数: 57 · 论文数: 493
胡燕 封面图
胡燕 (Yan Hu)
H 指数: 53 · 论文数: 221
查看更多